“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research.
The award — established in 2025 by SCCT...
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research.
The award — established in 2025 by SCCT...
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Key Highlights
The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.
With five different lengths and six different French sizes,...
Key Highlights
The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.
With five different lengths and six different French sizes,...
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
